22:46:07 EDT Wed 17 Jul 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
MOBERG PHARMA AB
Symbol U : MBGRF
Recent Sedar Documents

Moberg Pharma Gives Notice of Early Redemption of Bonds With ISIN SE0007953989

2019-04-01 02:43 ET - News Release

STOCKHOLM, April 1, 2019 /PRNewswire/ -- On February 12th, 2019, it was announced that Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has entered into agreement with RoundTable Healthcare Partners and Signet Healthcare Partners to divest the entire commercial operation and that the Company intends to redeem its outstanding bonds 2016/2021 with ISIN SE0007953989 (the "Bonds") in connection with closing of the transaction. On March 29th, 2019, it was announced that closing of the transaction has taken place and the Company will therefore redeem the Bonds in accordance with the terms and conditions for the Bonds.

On April 1st, 2019, the Company sent an irrevocable notice of early redemption to all directly registered owners and registered authorised nominees (Sw. förvaltare) in the debt register for the Bonds kept by Euroclear Sweden as of March 29th, 2019.

The early redemption date is set to April 29th, 2019. In accordance with the terms and conditions, the Bonds will be redeemed at an amount equal to 104.00 per cent. of the nominal amount (i.e.SEK 1,040,000 per Bond).

The redemption amount, together with accrued and unpaid interest up to and including the early redemption date, will be paid to each person who is registered as owner of Bonds in the debt register maintained by Euroclear Sweden at end of business on April 18th, 2019. In connection with the redemption, the Bonds will be delisted from Nasdaq Stockholm.

This press release is for information purposes only and is not to be construed as an offer to purchase or sell or a solicitation of an offer to purchase or sell with respect to any securities of the Company.

For additional information, please contact: 
Peter Wolpert, CEO, phone: Sweden: +46-707-35-7135, US: +1-908-432-2203, e-mail: peter.wolpert@mobergpharma.se

Anna Ljung, CFO, phone: +46-707-66-6030, e-mail: anna.ljung@mobergpharma.se

About this information

The information was submitted for publication, through the contact persons set out above, at 8.30 a.m. (CET) on April 1st, 2019.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/moberg-pharma/r/moberg-pharma-gives-notice-of-early-redemption-of-bonds-with-isin-se0007953989,c2775881

The following files are available for download:

https://mb.cision.com/Main/1662/2775881/1016939.pdf

Moberg Pharma gives notice of early redemption of bonds with ISIN SE0007953989

 

View original content:http://www.prnewswire.com/news-releases/moberg-pharma-gives-notice-of-early-redemption-of-bonds-with-isin-se0007953989-300821614.html

SOURCE Moberg Pharma

© 2019 Canjex Publishing Ltd. All rights reserved.